COMMITTED
TO EXCEPTIONAL ACCESS

PAYERS COVER RINVOQ after the trial of 1 TNFi (branded or biosimilar) with ~99 percent PREFERRED COMBINED COMMERCIAL AND MEDICARE PART D COVERAGE. National Commercial and Medicare Part D formulary coverage under the pharmacy benefit as of November 2025 in RA, PsA, AS, and nr-axSpA.

What Can Preferred Coverage Mean for Your Patients?

PREFERRED* Coverage Means

  • RINVOQ is covered as a first-line therapy for GCA, and after the trial of 1 TNFi for RA, PsA, AS, and nr‑axSpA,
    ahead of non-preferred products
  • At the lowest branded copay/coinsurance tier

Affordability Options For Your Eligible Patients

of Commercial claims for a filled RINVOQ prescription cost patients

Your eligible, commercially insured patients may pay as little as $0 per month with the RINVOQ Complete Savings Card.§

*RINVOQ is on a preferred tier or otherwise has preferred status on the plan's formulary.

Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.

Based upon paid Commercial claims data from national data providers for a filled RINVOQ prescription for RA, PsA, AS, nr-axSpA, and GCA for the period May 2025-April 2026, inclusive of savings card redemptions.5


Patient’s actual out-of-pocket cost may vary depending on their insurance coverage and eligibility for support programs. Patient’s actual out-of-pocket cost may vary depending on their insurance coverage and eligibility for support programs.

§RINVOQ Complete Savings Card Terms and Conditions Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

AS=ankylosing spondylitis; IR=intolerance or inadequate response; GCA=giant cell arteritis; nr-axSpA=non-radiographic axial spondyloarthritis; PsA=psoriatic arthritis; RA=rheumatoid arthritis; TNFi=tumor necrosis factor inhibitor.

Check the Formulary Status for RINVOQ in Your Area

Formulary Zipcode


Select a filter

Choose Indication

Please enter a valid zip code.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Formulary Status Results

  • Plan Name
  • Plan Type
  • Status

Results ends here

  • Plan Name
  • Plan Type
  • Status

Results ends here

Preferred means RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.

AS=active ankylosing spondylitis*; IR=intolerance or inadequate response; nr-axSpA=active non-radiographic axial spondyloarthritis; PsA=active psoriatic arthritis*; RA=moderate to severe rheumatoid arthritis*; TNFi=tumor necrosis factor inhibitor.

*In adult TNFi-IR patients.

In adult TNFi-IR patients with objective signs of inflammation.

What could your patients pay for RINVOQ?

ANTHONY

COMMERCIALLY INSURED

As an eligible, commercially insured patient, Anthony pays $0 per month for his RINVOQ prescription.*

Find out how

CHERYL

MEDICARE PART D

As a standard Medicare Part D patient enrolled in the Medicare Prescription Payment Plan, Cheryl pays $175 per month for all her prescriptions.6

Find out how

JOEY

MEDICARE PART D WITH EXTRA HELP

As a Medicare Part D Extra Help patient, Joey pays $12.65 per prescription for RINVOQ.7

Find out how

Final patient out-of-pocket costs may vary based on a number of factors, including but not limited to a patient's insurance coverage,
plan design, and Medicare Extra Help qualified enrollment.

*RINVOQ Complete Savings Card Terms and Conditions Eligibility: Available to patients with commercial insurance coverage for RINVOQ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

Enroll your patients in

at the time of prescription to help them access potential savings and exceptional 1:1 support